PTC Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for PTC Therapeutics, Inc. (PTCT) is 6.11B

According to PTC Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.11B. This represents a change of 29.76% compared to the average of 4.71B of the last 4 quarters.

PTC Therapeutics, Inc. (PTCT) Historical Enterprise Value (quarterly & annually)

How has PTCT Enterprise Value performed in the past?

The mean historical Enterprise Value of PTC Therapeutics, Inc. over the last ten years is 3.17B. The current 6.11B Enterprise Value has changed 19.19% with respect to the historical average. Over the past ten years (40 quarters), PTCT's Enterprise Value was at its highest in in the December 2025 quarter at 5.64B. The Enterprise Value was at its lowest in in the December 2016 quarter at 239.33M.

PTC Therapeutics, Inc. (PTCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PTC Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PTC Therapeutics, Inc. (PTCT) Average Enterprise Value

How has PTCT Enterprise Value performed in the past?

The current Enterprise Value of PTC Therapeutics, Inc. (PTCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PTC Therapeutics, Inc. (PTCT) Enterprise Value vs. Peers

How is PTCT’s Enterprise Value compared to its peers?

PTC Therapeutics, Inc.’s Enterprise Value is less than Alkermes plc (8.73B), less than Krystal Biotech, Inc. (9.77B), less than Metsera, Inc. (6.98B), less than Arrowhead Pharmaceuticals, Inc. (12.71B), less than TG Therapeutics, Inc. (8.46B), less than Vaxcyte, Inc. (7.28B), less than Arcellx, Inc. (6.75B), greater than Atrium Therapeutics, Inc. (-48611560.00), less than Protagonist Therapeutics, Inc. (7.07B), greater than Crinetics Pharmaceuticals, Inc. (3.72B),

Build a custom stock screener for PTC Therapeutics, Inc. (PTCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PTC Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PTC Therapeutics, Inc. (PTCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PTC Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.